-
Patterns of care in relapsed/refractory multiple myeloma in China: a real-world physician survey stud
Author: Wu, Di; Murali, Bhavna; Clark, Otavio; Luan, Luan; Hlavacek, Patrick; Chaudhary, Mohammed Ashraf; Aydin, Didem; DiBonaventura, Marco
Journal: FUTURE ONCOLOGY. 2026; Vol. 22, Issue 10, pp. 1213-1219. DOI: 10.1080/14796694.2026.2656394
-
SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCL
Author: Peters, Solange; Hochmair, Maximilian; Arbour, Kathryn C.; Rodriguez, Luis Paz-Ares; Reck, Martin; Leal, Ticiana; R. Lindsay, Colin; Shun, Lu; William, William Nassib; Spira, Alexander I.; Sabari, Joshua K.; Henning Grønberg, Bjørn; Nishio, Makoto; Burns, Timothy F.; Girard, Nicolas; Capuzzo, Frederico; Merced, Alyson; Fasnacht, Nicolas; Visseren-Grul, Carla; Negrao, Marcelo V
Journal: FUTURE ONCOLOGY. 2026; Vol. 22, Issue 9, pp. 1073-1082. DOI: 10.1080/14796694.2026.2651961
-
Comparison of concurrent chemoradiotherapy followed by immunotherapy and induction chemoimmunotherapy followed by radiotherapy in unresectable stage III NSCLC: a retrospective cohort stud
Author: Xu, Qinhao; Qi, Yana; Zhai, Xiaoyang; Chen, Feihu; Guo, Yingfan; Zhu, Hui
Journal: FUTURE ONCOLOGY. 2026; Vol. 22, Issue 7, pp. 819-829. DOI: 10.1080/14796694.2026.2637732
-
Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial design
Author: Yu, Evan Y.; Gratzke, Christian; Burotto, Mauricio; Zhang, Alison Y.; Levesque, Eric; Ortega, Francisco; Peer, Avivit; Vile, Donald; Chen, Zheng Hong; Song, Yue; Schloss, Charles; Todoric, Jelena; Garratt, Chris; Poehlein, Christian; Antonarakis, Emmanuel S.; Fizazi, Karim
Journal: FUTURE ONCOLOGY. 2026; Vol. 22, Issue 7, pp. 765-772. DOI: 10.1080/14796694.2025.2595914
-
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumor
Author: Schram, Alison M.; Park, John J.; Italiano, Antoine; Kitano, Shigehisa; Guo, Ye; Li, Jin; Bedard, Philippe L.; van Marcke, Cedric; Ko, Ryo; Lunger, Lukas; Klotz, Daniel M.; Hussain, Jo; Maier, Daniela; Erzen, Damijan; Planchard, David; Prenen, Hans; Clay, Timothy D.; Park, Joon O.; Kim, Hyung-Don; Hernando-Calvo, Alberto; Maruki, Yuta; Ponz-Sarvise, Mariano; Dumbrava, Ecaterina
Journal: FUTURE ONCOLOGY. 2026; Vol. 22, Issue 7, pp. 795-803. DOI: 10.1080/14796694.2026.2637740
-
Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Tria
Author: Hao, Shengnan; Wang, Xiaomin; Ding, Huiping; Chen, Yun; Liu, Qi; Zhang, Junhua; Fan, Xingwen; Wu, Zhenhua; Lin, Ying; Xu, Xiaofang; Mao, Guangmin; Ai, Dashan; Deng, Jiaying; Zhu, Hongcheng; Ye, Jinjun; Mo, Miao; Hu, Zhihuang; Wang, Huijie; Cheng, Wenwu; Feng, Wei; Ling, Yiqun; Xu, Yufen; Du, Shisuo; Wang, Jialei; Zhao, Kuaile
Journal: FUTURE ONCOLOGY. 2026; Vol. 22, Issue 7, pp. 773-780. DOI: 10.1080/14796694.2026.2637738
-
Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summar
Author: Chen, Li-Tzong; Kang, Yoon-Koo; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Chung, Ik-Joo; Yamaguchi, Kensei; Kato, Ken; Sym, Sun Jin; Kadowaki, Shigenori; Tsuji, Kunihiro; Chen, Jen-Shi; Bai, Li-Yuan; Oh, Sung-Yong; Choda, Yasuhiro; Yasui, Hisateru; Takeuchi, Kentaro; Hirashima, Yoshinori; Hagihara, Shunsuke; Boku, Narikazu
Journal: FUTURE ONCOLOGY. 2026; Vol. 22, Issue 6, pp. 625-642. DOI: 10.1080/14796694.2026.2622806
-
Efficacy and safety of anti-CLDN18.2 therapies in advanced or metastatic gastric, gastro-oesophageal junction, and oesophageal carcinomas with CLDN18.2 positivity: a systematic review and meta-analysi
Author: Zhang, Yaping; Kao, Shangbin; Li, Dian; Yan, Canlong; Huang, Biao; Fang, Hongming
Journal: FUTURE ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/14796694.2026.2659354
